CTLA4 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), Wang et al. reported that CTLA-4 blockade has the potential to stimulate tumor cell pyroptosis through STAT1/IRF1 axis, generating large amounts of chemokines and inflammatory substances such as TNF-α and IFN-γ [438].